Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer.
Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer. Future Med Chem. 2017 04; 9(5):469-483.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Computer Simulation
Drug Screening Assays, Antitumor
ErbB Receptors
Humans
Lung Neoplasms
Models, Molecular
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Quantitative Structure-Activity Relationship
Small Molecule Libraries
Structure-Activity Relationship
authors with profiles
Pankaj Kumar Singh